Treatment and prognosis of heart valve registry

Not Applicable

Recruiting

• Conditions: aortic stenosis/mitral regurgitation

• Registration Number: JPRN-UMIN000023653
• Lead Sponsor: OCEAN-SHD organization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-17
• Last Update Posted: 17 October 2023
• Study Completion: 2028-04-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

Not provided

Exclusion Criteria

The patients who are under the 20 years old or who are found unfit to be respondent to a survey by physician-in-charge

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
During follow the natural history: 1. Mortality (all cause mortality, cardiovascular death, non-cardiovascular death) 2. Invasive procedure (surgical aortic valve replacement, mitral valve replacement, Transcatheter Aortic Valve Implantation, mitral valvuloplasty and Mitral Clip) 3. Admission of heart failure 4. Progression of heart valve by transthoracic echocardiography (increase of max velocity and pressure gradient, decrease of aortic valve area, and exacerbation of mitral regurgitation) After the invasive procedure: 1. Perioperative period: in-hospital death, complication (myocardial infarction, cardiac tamponade, vascular accident, auriculoventricular block for needing pacemaker, cerebral infarction, bleeding for needing blood transfusion) 2. Follow-up 1year, 2year, 3year, 4year, 5year after procedure: presence or absence of admission of heart failure, presence or absence of the death (cardiovascular death, non-cardiovascular death)